ALEXANDRIA, Va., April 15 -- United States Patent no. 12,601,742, issued on April 14, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.) and University of Iowa Research Foundation (Iowa City, Iowa).

"Methods and materials for treating endometrial cancer by assessing combinations of mutations and expression levels" was invented by Karl C. Podratz (Rochester, Minn.) and Jesus Gonzalez Bosquet (Iowa City, Iowa).

According to the abstract* released by the U.S. Patent & Trademark Office: "This document relates to methods and materials for assessing and/or treating mammals (e.g., humans) having endometrial cancer. For example, methods and materials for identifying endometrial cancers likely to respond to a par...